VERQUVO 2.5 mg/1
vericiguat · TABLET, FILM COATED · Merck Sharp & Dohme LLC
Vericiguat is a prescription tablet used to reduce the risk of hospitalization in patients with heart failure who have recently had a heart attack or worsening heart failure symptoms. It works by stimulating an enzyme called soluble guanylate cyclase to help improve heart function.
Key Facts
- Brand Name
- VERQUVO
- Generic Name
- vericiguat
- NDC Code (Product)
0006-5028- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 2.5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA214377
- Drug Class
- Soluble Guanylate Cyclase Stimulator [EPC]
- Marketing Start
- 02/01/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is VERQUVO used for?
Vericiguat is a prescription tablet used to reduce the risk of hospitalization in patients with heart failure who have recently had a heart attack or worsening heart failure symptoms. It works by stimulating an enzyme called soluble guanylate cyclase to help improve heart function.
Is VERQUVO a controlled substance?
VERQUVO is not classified as a controlled substance by the DEA.
What is the generic name for VERQUVO?
The generic name for VERQUVO is vericiguat. There are no other listed brand versions of vericiguat.
What is the NDC code for VERQUVO 2.5 mg/1?
The NDC (National Drug Code) for VERQUVO 2.5 mg/1 is 0006-5028, listed by Merck Sharp & Dohme LLC.
Other VERQUVO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)